Macflox Tablet contains Moxifloxacin 400 mg, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as community-acquired pneumonia, acute bacterial sinusitis, and chronic bronchitis exacerbations. Additionally, Macflox is used to manage skin and soft tissue infections, intra-abdominal infections, and certain types of bacterial conjunctivitis. Moxifloxacin exerts its bactericidal action by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair, thereby preventing bacterial cell proliferation. The tablet formulation ensures convenient oral administration with good bioavailability. Macflox should be prescribed based on susceptibility testing and is contraindicated in patients with known hypersensitivity to fluoroquinolones. Caution is advised in patients with a history of tendon disorders related to fluoroquinolone use, QT interval prolongation, or epilepsy. Common adverse effects include gastrointestinal disturbances, headache, and dizziness. It is important to complete the full course of therapy to prevent the development of resistance. Macflox Tablet should be used under medical supervision to ensure appropriate use and monitoring for potential side effects.